EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitral valve surgery after failed transcatheter edge-to-edge repair: eight-year survival and functional outcomes from two centers

Lilly Ilcheva Burger, Marta Ambrus, Can Keskinaslan, Rasha Boulos, Petar Risteski, Igor Tudorache, Nestoras Papadopoulos, Hector Rodriguez Cetina Biefer, Omer Dzemali

Frontiers in Cardiovascular Medicine · 20.11.2026 · 13

DOI: 10.3389/fcvm.2026.1980699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 20.11.2026. Verfasst von Lilly Ilcheva Burger und 8 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transcatheter edge-to-edge repair (TEER) is increasingly offered to patients at low and intermediate surgical risk, yet the outcomes of mitral valve surgery after failed TEER remain poorly defined, and long-term data are scarce.

Methods

We retrospectively analyzed all consecutive patients who underwent mitral valve surgery after failed TEER at two Swiss centers between January 2017 and April 2024. The primary endpoint was Kaplan–Meier survival; secondary endpoints were perioperative complications and changes in New York Heart Association ( N YHA) class, left ventricular ejection fraction (LVEF) and mitral regurgitation (MR) grade, assessed by transthoracic echocardiography before discharge after TEER and before surgery. Cause-specific mortality was analyzed with competing-risk methods.

Results

Thirty-five patients were included (median age 76 years at surgery; primary MR in 29, 82.9%). Most had been discharged after TEER with non-severe MR (23/35, 65.7%) and underwent surgery more than 30 days later (23/35, 65.7%); severe MR was present in 12 patients (34.3%) at discharge after TEER and in 28 (80.0%) before surgery. Median EuroSCORE II rose from 2.9 (1.6–3.8) before TEER to 6.3 (3.7–17.0) before surgery ( p < 0.001). Repair was achieved in 4 patients (11.4%). In-hospital mortality was 2.9%, but morbidity was substantial: pneumonia occurred in 28.6%, renal replacement therapy in 17.1% and tracheostomy in 11.4%, and median hospital stay was 15 days. Kaplan–Meier survival was 91.4%, 72.5% and 59.0% at 1, 3 and 5 years (32, 21 and 12 at risk); the 8-year estimate of 40.2% rests on a single patient at risk and is exploratory. Eight of 14 deaths were cardiac. No surviving patient had severe MR or NYHA class III–IV at one year.

Conclusion

Mitral valve surgery after failed TEER was performed with low in-hospital mortality but substantial morbidity, and repair was achieved in only one in nine patients. Most patients came to surgery after later deterioration rather than immediate procedural failure. Durability, rather than acute procedural success, should therefore inform the choice of TEER, particularly in younger and lower-risk patients, and surveillance after TEER should extend beyond the index hospitalization.

Zitieren

APA

Burger, L. I., Ambrus, M., Keskinaslan, C., Boulos, R., Risteski, P., Tudorache, I., Papadopoulos, N., Biefer, H. R. C., & Dzemali, O. (2026). Mitral valve surgery after failed transcatheter edge-to-edge repair: eight-year survival and functional outcomes from two centers. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1980699

Vancouver

Burger LI, Ambrus M, Keskinaslan C, Boulos R, Risteski P, Tudorache I, et al. Mitral valve surgery after failed transcatheter edge-to-edge repair: eight-year survival and functional outcomes from two centers. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1980699

BibTeX
@article{Burger2026,
  author = {Burger, Lilly Ilcheva and Ambrus, Marta and Keskinaslan, Can and Boulos, Rasha and Risteski, Petar and Tudorache, Igor and Papadopoulos, Nestoras and Biefer, Hector Rodriguez Cetina and Dzemali, Omer},
  title = {Mitral valve surgery after failed transcatheter edge-to-edge repair: eight-year survival and functional outcomes from two centers},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1980699}
}
Kostenlos starten →